Emerging strategies for chronic heart failure: the role of gene therapy

Area of Science:

• Cardiology
• Molecular Medicine
• Public Health

Background:

• Heart failure (HF) is a complex clinical syndrome with increasing incidence, particularly in aging populations.
• It is a leading cause of death and morbidity, posing significant public health challenges.
• Current pharmacological treatments target neurohormonal and adrenergic systems but have limitations in advanced stages.

Purpose of the Study:

• To present current medical management strategies for clinical heart failure.
• To introduce novel gene therapies as a potential treatment approach for HF.
• To highlight the aim of gene therapy in addressing molecular abnormalities underlying HF.

Main Methods:

• Review of current pharmacological treatments for heart failure.
• Exploration of emerging gene therapy strategies for HF treatment.
• Analysis of pathophysiological mechanisms in HF progression.

Main Results:

• Pharmacological treatments aim to modulate key pathophysiological pathways.
• Despite advancements, end-stage HF patients often have a poor prognosis.
• Gene therapy presents a novel approach to correct molecular defects in HF.

Conclusions:

• Effective management of heart failure remains challenging due to its complexity.
• Current therapies offer symptomatic relief but do not fully resolve the disease.
• Gene therapy holds promise for a more curative approach to heart failure by targeting its root molecular causes.